Fungal diseases are neglected worldwide by public health authorities. GAFFI efforts are directed at:
- Identifying and publicising gaps in diagnostics and treatments for fungal diseases,
- Consulting on how services could be improved through facilitating training, encouraging companies to expand their markets and recommending improvements in infrastructure,
- Estimating the burden of serious fungal diseases, country by country. Over 65 countries with a population >1 million have been addressed, and many are published (view),
- Develop, implement and evaluate country-wide diagnostic programs. Guatemala (fungal infections in AIDS) is the first (view)
- Influence national and international agencies to ‘adopt’ fungal diseases alongside existing programs including TB, microbiology, AMR, NTDs and incorporation of key generic antifungals onto the WHO Essential Medicines List.
- Focussed diagnostic improvements for GAFFI’s priority diseases.
Globally, over 300 million people of all ages suffer from a serious fungal infection every year. Of these over 1.66 million people are estimated to die. Most serious fungal infections are ‘hidden’ because of other health problems.
The objective: 95% of patients with serious fungal infections are diagnosed and treated.